Business Context and Reporting Period
This Form 6-K filing by Cameco Corporation, dated June 17, 2004, reports on a material agreement amendment finalized on June 16, 2004. Cameco, the world's largest uranium producer, is a foreign private issuer reporting pursuant to Rule 13a-16. The filing details an amendment to the High Enriched Uranium (HEU) Contract involving Cameco, COGEMA, RWE NUKEM, and the Russian state agency Techsnabexport (Tenex).
Key Financial Metrics and Contractual Data
The filing does not provide standard financial statements (revenue, profit, cash flow, or margins) for a specific reporting period. Instead, it outlines significant contractual volumes and commitments:
- Annual HEU Delivery: Russia delivers the equivalent of 24 million pounds of uranium derived from HEU annually to the United States.
- Tenex Direct Sales: Tenex currently sells approximately 6 million pounds per year directly, increasing to about 8 million pounds annually in coming years.
- Monitored Inventory: As of the end of 2003, approximately 44 million pounds of uranium were held in a U.S.-monitored inventory.
- Firm Commitments: Western companies have firm purchase commitments for almost 163 million pounds of uranium from the date of the filing through the end of 2013.
- US Sales Quotas: Annual legislated quotas for sales into the U.S. range from 14 million pounds in 2004 to 20 million pounds annually from 2009 to 2013.
Material Changes Versus Prior Period
The primary material change is the amendment to the HEU Contract to ensure its operation through 2013. Key changes include:
- Waiver of Second Options: Western companies agreed to waive their rights to purchase uranium from the monitored inventory (44 million pounds) for the remainder of the agreement.
- Reduction in Non-US Supply: The amendment reduces the amount of "second option" material available for delivery outside the U.S. market by approximately 74 million pounds through 2013.
- Return of Material to Russia: Beginning around 2008, Tenex will return approximately 7 million pounds of HEU-derived uranium annually to Russia to facilitate blending requirements, rather than selling it to the western market.
- Conversion Impact: The reduction in available material includes a contained conversion component of approximately 28,000 tonnes of U as UF6.
Guidance, Outlook, and Risks
Management Commentary: Cameco's President and CEO, Jerry Grandey, stated the company is proud to be part of an initiative turning Russian nuclear weapons into fuel for clean energy. The amendment ensures the continued operation of the HEU Contract despite Russia's rising domestic uranium requirements.
Risks and Contingencies:
- Regulatory Approval: The amendment is subject to approval by both the U.S. and Russian governments.
- Market Volatility: Forward-looking statements are subject to risks including uranium price volatility, foreign currency exchange rates, and changes in government regulations.
- Operational Risks: Risks include environmental and safety issues, geological conditions, political risks in developing countries, and potential deterioration in political support for nuclear energy.
- Supply Constraints: The reduction in available non-quota HEU-derived uranium may impact supply availability for markets outside the United States.
Key Facts for Investor Verification
- Verify the status of U.S. and Russian government approvals required for the HEU Contract amendment.
- Assess the impact of the 74 million pound reduction in non-U.S. market supply on Cameco's future revenue streams and conversion services.
- Monitor the 163 million pounds of firm purchase commitments and their alignment with current market demand.
- Review the specific terms regarding the 28,000 tonnes of UF6 conversion component reduction.
- Track the annual U.S. sales quotas (14 to 20 million pounds) and their effect on Tenex's direct sales versus western company options.